| Tipo : |
Periódico |
| Enlace : |
https://doi.org/10.1016/j.ijpharm.2005.08.007 |
|
| Los equipos de investigación : |
Ann Arbor - Pfizer Global Research & Development |
| Autores : |
Freed A.L, Silbering S.B, Kolodsick K.J, Rossi D, Mahjour M, Kingsmill C.A. |
| Título : |
The development and stability assessment of extemporaneous pediatric formulations of Accupril. |
| Número : |
Int J Pharm 304; 1-2: 135-144. 2005 |
|
| Nivel de evidencia : |
|
| La estabilidad física : |
|
| Estabilidad química : |
|
| Otros métodos : |
|
| Comentarios : |
|
Lista de la molécula
 Quinapril
|
 |
 |
 |
 |
200 mg
Accupril® |
| Kphos® |
30 ml |
| Bicitra® |
30 ml |
| Orasweet® |
>> 200 ml |
|
5°C |
 |
| 42 |
 |
|
|
|
|
|
200 mg
Accupril® |
| Kphos® |
30 ml |
| Bicitra® |
30 ml |
| Orasweet SF ® |
>> 200 ml |
|
5°C |
|
| 42 |
|
|
|
|
|
|
200 mg
Accupril® |
| Kphos® |
30 ml |
| Bicitra® |
30 ml |
| Jarabe simple |
>> 200 ml |
|
5°C |
|
| 42 |
|
|
|
|
|
